Cite
Miano M, Scalzone M, Perri K, et al. Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience. Br J Haematol. 2015;171(2):247-253doi: 10.1111/bjh.13533.
Miano, M., Scalzone, M., Perri, K., Palmisani, E., Caviglia, I., Micalizzi, C., Svahn, J., Calvillo, M., Banov, L., Terranova, P., Lanza, T., Dufour, C., & Fioredda, F. (2015). Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience. British journal of haematology, 171(2), 247-253. https://doi.org/10.1111/bjh.13533
Miano, Maurizio, et al. "Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience." British journal of haematology vol. 171,2 (2015): 247-253. doi: https://doi.org/10.1111/bjh.13533
Miano M, Scalzone M, Perri K, Palmisani E, Caviglia I, Micalizzi C, Svahn J, Calvillo M, Banov L, Terranova P, Lanza T, Dufour C, Fioredda F. Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience. Br J Haematol. 2015 Oct;171(2):247-253. doi: 10.1111/bjh.13533. Epub 2015 Jun 08. PMID: 26058843.
Copy
Download .nbib